631 research outputs found
A comparison of acyltransferase activities in vitro with the distribution of fatty acids in lecithins and triglycerides in vivo
The location and configuration of a double bond in a fatty acid influences the rate of its acyltransferase‐catalyzed esterification to form lecithin and its distribution in vivo between the primary and secondary positions of triglycerides and lecithins.Saturated acids of shorter chain length are transferred at rates similar to the long chain unsaturated acids.The positional distributions of acids in the diglyceride units of liver triglycerides appear to be similar to that found in the lecithins.Acyltransferase activities measured in vitro have a considerable predictive value in terms of the ultimate distribution of fatty acids in glycerolipids in vivo.Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/141483/1/lipd0224.pd
Incorporation of ricinoleic acid into glycerolipids
The coenzyme A thiol ester of ricinoleic acid was synthesized and characterized. Ricinoleoyl-CoA has been tested as an acyl donor in several in vitro systems using rat liver microsomal acyltransferases.It is essentially inactive when 1-acyl- or 2-acyl-sn-glycerol-3-phosphoryl choline are used as acceptors, however, it can serve as acyl donor when glycerol-3-phosphate or 1-acyl-sn-glycerol-3-phosphate are acceptors to yield di- and monoricinoleoyl glycerol-3-phosphates, respectively. A high apparent Km (50 [mu]M) for ricinoleoyl-CoA may explain the fact that ricinoleic acid appears to be excluded from phospholipids in vivo.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/33531/1/0000030.pd
Meeting Report: Consensus Recommendations for a Research Agenda in Exercise in Solid Organ Transplantation
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/108597/1/ajt12874.pd
Effect of metal-complexing agents on the oxygenase activity of sheep vesicular glands
A variety of agents that are known to complex copper can reversibly inhibit the oxygenation of unsaturated fatty acids by particulate preparations from sheep vesicular glands. The time-dependent activation of the oxygenase preparation by phenol, on the other hand, was not affected by the copper chelator, diethyldithiocarbamate. The results suggest that protein-bound copper could play a role in the interaction of the oxygenase enzyme with oxygen and the fatty acid substrates. Other findings indicate that phenanthroline type compounds may inhibit both the oxygenation reaction and phenol activation by binding to an hydrophobic site on the oxygenase.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/33775/1/0000028.pd
The Subcellular Distribution of Acyltransferases which Catalyze the Synthesis of Phosphoglycerides
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/65213/1/j.1432-1033.1969.tb00602.x.pd
Assessment: How Hard Can It Be?
Demonstrate how assessment of a curriculum-based education program can work. Share results of the Forever Earth program assessment Stimulate thought and discussion of how to implement assessment strategies for your program
Biochemistry of the sphingolipides. X. Phytoglycolipide, a complex phytosphingosine‐containing lipide from plant seeds
Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/141721/1/aocs0335.pd
A phase II study on safety and efficacy of high-dose N-acetylcysteine in patients with cystic fibrosis
<p>Abstract</p> <p>Objective</p> <p>We conducted a single-centre, randomised, double-blinded, placebo-controlled phase II clinical study to test safety and efficacy of a 12-week therapy with low-dose (700 mg/daily) or high-dose (2800 mg/daily) of NAC.</p> <p>Methods</p> <p>Twenty-one patients (ΔF508 homo/heterozygous, FEV<sub>1 </sub>> 40% pred.) were included in the study. After a 3-weeks placebo run-in phase, 11 patients received low-dose NAC, and 10 patients received high-dose NAC. Outcomes included safety and clinical parameters, inflammatory (total leukocyte numbers, cell differentials, TNF-α, IL-8) measures in induced sputum, and concentrations of extracellular glutathione in induced sputum and blood.</p> <p>Results</p> <p>High-dose NAC was a well-tolerated and safe medication. High-dose NAC did not alter clinical or inflammatory parameters. However, extracellular glutathione in induced sputum tended to increase on high-dose NAC.</p> <p>Conclusions</p> <p>High-dose NAC is a well-tolerated and safe medication for a prolonged therapy of patients with CF with a potential to increase extracellular glutathione in CF airways.</p
Cardiopulmonary Exercise Testing Provides Additional Prognostic Information in Cystic Fibrosis
RATIONALE: The prognostic value of cardiopulmonary exercise testing (CPET) for survival in cystic fibrosis (CF) in the context of current clinical management, when controlling for other known prognostic factors, is unclear.
OBJECTIVES: To determine the prognostic value of CPET-derived measures beyond peak oxygen uptake (V.o2peak) following rigorous adjustment for other predictors.
METHODS: Data from 10 CF centers in Australia, Europe, and North America were collected retrospectively. A total of 510 patients completed a cycle CPET between January 2000 and December 2007, of which 433 fulfilled the criteria for a maximal effort. Time to death/lung transplantation was analyzed using Cox proportional hazards regression. In addition, phenotyping using hierarchical Ward clustering was performed to characterize high-risk subgroups.
MEASUREMENTS AND MAIN RESULTS: Cox regression showed, even after adjustment for sex, FEV1% predicted, body mass index (z-score), age at CPET, Pseudomonas aeruginosa status, and CF-related diabetes as covariates in the model, that V.o2peak in % predicted (hazard ratio [HR], 0.964; 95% confidence interval [CI], 0.944–0.986), peak work rate (% predicted; HR, 0.969; 95% CI, 0.951–0.988), ventilatory equivalent for oxygen (HR, 1.085; 95% CI, 1.041–1.132), and carbon dioxide (HR, 1.060; 95% CI, 1.007–1.115) (all P < 0.05) were significant predictors of death or lung transplantation at 10-year follow-up. Phenotyping revealed that CPET-derived measures were important for clustering. We identified a high-risk cluster characterized by poor lung function, nutritional status, and exercise capacity.
CONCLUSIONS: CPET provides additional prognostic information to established predictors of death/lung transplantation in CF. High-risk patients may especially benefit from regular monitoring of exercise capacity and exercise counseling
Limited Effect of Dietary Saturated Fat on Plasma Saturated Fat in the Context of a Low Carbohydrate Diet
We recently showed that a hypocaloric carbohydrate restricted diet (CRD) had two striking effects: (1) a reduction in plasma saturated fatty acids (SFA) despite higher intake than a low fat diet, and (2) a decrease in inflammation despite a significant increase in arachidonic acid (ARA). Here we extend these findings in 8 weight stable men who were fed two 6-week CRD (12%en carbohydrate) varying in quality of fat. One CRD emphasized SFA (CRD-SFA, 86 g/d SFA) and the other, unsaturated fat (CRD-UFA, 47 g SFA/d). All foods were provided to subjects. Both CRD decreased serum triacylglycerol (TAG) and insulin, and increased LDL-C particle size. The CRD-UFA significantly decreased plasma TAG SFA (27.48 ± 2.89 mol%) compared to baseline (31.06 ± 4.26 mol%). Plasma TAG SFA, however, remained unchanged in the CRD-SFA (33.14 ± 3.49 mol%) despite a doubling in SFA intake. Both CRD significantly reduced plasma palmitoleic acid (16:1n-7) indicating decreased de novo lipogenesis. CRD-SFA significantly increased plasma phospholipid ARA content, while CRD-UFA significantly increased EPA and DHA. Urine 8-iso PGF2α, a free radical-catalyzed product of ARA, was significantly lower than baseline following CRD-UFA (−32%). There was a significant inverse correlation between changes in urine 8-iso PGF2α and PL ARA on both CRD (r = −0.82 CRD-SFA; r = −0.62 CRD-UFA). These findings are consistent with the concept that dietary saturated fat is efficiently metabolized in the presence of low carbohydrate, and that a CRD results in better preservation of plasma ARA
- …